Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)
Status:
Terminated
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The study will explore the neurocognitive effect of four weeks of treatment with amantadine
versus placebo in patients with traumatic brain injury using the Interval Bisection Timing
Task. Approximately 16 individuals with traumatic brain injury are expected to participate in
this study. Subject participation is expected to last up to 8 weeks with 16 study visits.